SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing intense downward pressure as investors weigh ongoing brand competition from emerging footwear rivals against negative analyst downgrades, fueling a contentious debate among the community about whether the stock is a deep-value opportunity near multi-year lows or a structural value trap. While some traders are aggressively accumulating shares and leveraging long-term calls in anticipation of a potential turnaround, bears remain focused on the stock's persistent inability to hold technical support levels.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as retail investors rally behind the company's strong patent portfolio and recent legal victories, particularly the strategic Samsung settlement that provided both cash and a supply chain advantage. The community is actively discussing the potential for a massive short squeeze and further licensing deals with industry giants like Micron and Google, fueling high levels of engagement and a surge in new watchers on the stock.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as investors react to a system outage that left many unable to execute trades, sparking frustration and community calls for compensation. While the stock has seen recent volatility, traders are actively debating the platform's reliability compared to competitors and expressing concerns over recurring technical failures.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the online community debate the company's long-term viability amid intense political polarization and negative sentiment regarding the stock's valuation. Discussion is heavily focused on broader political controversies and the platform's role in the current discourse rather than underlying financial fundamentals.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending due to a significant competitive catalyst following EyePoint Pharmaceuticals' failure to meet the primary endpoint in a late-stage trial for its rival wet AMD drug, which investors interpret as a major de-risking event for Ocular's lead candidate. Community sentiment is overwhelmingly bullish, with active discussions focusing on the elimination of a key market competitor, enhanced potential for a near-term buyout, and the overall strengthening of Ocular's position to capture the multi-billion dollar retinal disease market.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is trending as investors weigh an aggressive turnaround strategy centered on a 70 billion investment plan to revitalize core brands, alongside active community debate over its pivot back to internal combustion engines and ongoing concerns regarding inventory levels and geopolitical trade headwinds. Market participants are closely watching the automaker's recent partnership moves in the EV sector and its performance in key regions like North America, even as short interest remains a focal point for retail discussions.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors react to positive Phase III HARMONi-6 data, which showed improved overall survival for ivonescimab compared to current immunotherapy standards in first-line lung cancer. While the community is debating the trial's regional focus and the potential for regulatory hurdles, many remain bullish on the long-term potential of the drug to disrupt the current market leader.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing intense scrutiny as investors weigh the company's production scaling and high cash burn against strategic partnerships like the Volkswagen JV and Uber stake. While the community remains deeply polarized over management's execution and stock dilution, many are closely watching the upcoming R2 production shift as a critical catalyst for long-term profitability.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending as investors react to its new device-leasing partnership with Apple and anticipate a court ruling regarding an antitrust lawsuit against Google. While community members discuss potential buyout scenarios and the company's long-term potential as a fintech super-app, sentiment remains divided between optimistic long-term holders and traders focused on high volatility and short-term price swings.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is facing intense downward pressure following a post-earnings guidance reset that signaled a longer-than-expected path to recovery, with the stock currently trending as a battleground between frustrated retail investors and those watching for potential short-squeeze catalysts. While the community is actively debating the company's debt load and the competence of its leadership, sentiment remains sharply divided as traders weigh recent analyst downgrades against the stock's significant short interest and volatile price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y

PETS' fiscal first-quarter 2027 sales decline year over year, but lower costs, stronger recurring sales and new partnerships offer signs of progress.

PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates

PetMed (PETS) delivered earnings and revenue surprises of -333.33% and -20.64%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Commerce.com (CMRC) Q2 Earnings Surpass Estimates

Commerce.com (CMRC) delivered earnings and revenue surprises of +100.00% and -0.77%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

eBay (EBAY) Q2 Earnings and Revenues Top Estimates

eBay (EBAY) delivered earnings and revenue surprises of +5.96% and +3.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Chewy (CHWY) Up 10.1% Since Last Earnings Report: Can It Continue?

Chewy (CHWY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SilverCape Investments Announces Revised Proposal To Buy PetMed Express For $3/Share

(RTTNews) - Monday, Singapore-based SilverCape Investments Limited announced a revised proposal to acquire all outstanding shares of PetMed Express, Inc. (PETS) for $3.00 per share in cash...

PETS Q4 Earnings Call Focuses on Turnaround Foundation

PetMed says FY26 reset is working. Its Q4 sales top estimates, margins improve, and it stays independent after $4-$4.25 offers and touts B2B expansion.

PetMed Express (PETS) Q4 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates

PetMed (PETS) delivered earnings and revenue surprises of -5.56% and +1.27%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

PetMed Express Reports Q4 2026 Results: Full Earnings Call Transcript

PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs, cats, and horses. The firm provides treatments for allergies, arthritis, anxiety, dermatitis, diabetes, and heartworms. It offers access to a range of non-prescription health and wellness products and Rx food, non-Rx food, and treats. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Petmed Express, Inc.

Petmed Express Stock Jumps On Buyout Offer From Largest Shareholder SilverCape Investments

Equity

Extremely Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info